Anti-human IL23A Therapeutic antibody (6-22)

Recombinant monoclonal antibody 6-22 is a humanized monoclonal antibody that specifically binds to human IL-23 and can be potentially used in the treatment of psoriasis, Crohn's disease and multiple sclerosis.
Supplier Creative Biolabs
Product # TAB-610LC
Pricing Inquiry
Type Humanized antibody
Applications ELISA
Host Human
Target IL-23 (Interleukin 23)
Feedback